Moreover, CD9 expression may have prognostic significance for lobular carcinoma [54] and invasive breast carcinoma, depending on the histology of the CD9-expressing cells (tumor or stromal immune cells) and the molecular subtype [55]. This evidence concerns the gene CD9 and breast lobular carcinoma.